Dr Richard Lipscombe (Managing Director), Dr Javed Khan (Business Development/Computational Proteomics Scientist) and Mrs. Sreeja Sony (Regional Sales Manager-India) from Proteomics International (PI) had discussions with senior decision makers across the biotech and pharma sectors of Ahmedabad, Baroda and Mumbai between 8th and 12th May.
The company also hosted a networking event in Mumbai on 12th May where:
Mr. John Madew from Austrade delivered the Welcome address
Dr. Bangarurajan, Deputy Drug Controller (CDSCO) spoke about Current regulatory requirements for Biosimilar approvals in India
Dr. Venkataramana (Reliance Lifesciences) discussed Major issues with Biosimilar development; and
Dr. Richard Lipscombe (PI) presented the company’s diverse capabilities and latest developments in PI’s accredited biosimilars, analytics and biomarker services
Proteomics International – Global Leader In Protein Analysis
The event was well attended with delegates from major Indian biopharmas sharing useful conversations during a relaxed evening of networking over refreshments and dinner.
PI would like to thank the distinguished speakers and all those who attended for their participation and support in furthering PI’s ongoing effort to establish a networking/scientific discussion platform for groups from Indian biopharma industry.
